In a new job - February 10, 2023
XNK Therapeutics appoints new CMO
XNK Therapeutics has announced the appointment of Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Hovstadius will be a member of the company’s management team. Johan Aschan who retires from his position as CMO will continue as the company’s Senior Medical Advisor. “Peter has a solid background in oncology and clinical trials development from […]
In a new job - February 10, 2023
BerGenBio establish Oncology Scientific Advisory Board
BerGenBio has announced the formation of a scientific advisory board consisting of four non-small cell lung cancer (NSCLC) experts from top oncology centers around the globe to enhance the development of bemcentinib for the treatment of NSCLC patients with STK11 mutations. “We are very proud and honored to have assembled a group of leading international […]
In a new job - February 10, 2023
Patrik Renblad is leaving SynAct Pharma
SynAct Pharma has announced that its Chief Financial Officer, Patrik Renblad has resigned and will move to a new assignment outside of the company. He will leave SynAct by the end of July, 2023, at the latest. Patrik Renblad joined SynAct in 2021 and has during his tenure been instrumental in preparing the company for […]
In a new job - February 9, 2023
Lundbeck appoints new EVP and Head of Lundbeck in the US
Thomas (Tom) Gibbs is appointed as Executive Vice President and Head of Lundbeck in the United States. Tom will be based in Lundbeck’s U.S. head office in Chicago, Illinois, and assume the role no later than end of February 2023. “We look forward to having Tom join Lundbeck and the Executive Management team. He brings […]
In a new job - February 8, 2023
Oncopeptides appoints new Chief Financial Officer
The company has appointed Holger Lembrer as Chief Financial Officer, CFO. Prior to joining Oncopeptides Holger Lembrer was Business Unit CFO at Assa Abloy, and before that Investor Relations Officer, and Financial Controller. He has also been a Senior Auditor at Ernst & Young. Holger Lembrer will assume his new position before the end of […]
In a new job - January 13, 2023
He is the new Director General of Lif Sweden
Johan Färnstrand has been appointed new Director General of the trade association for the research-based pharmaceutical industry in Sweden. Färnstrand will start his new position on March 1st, succeeding Anders Blanck who leaves Lif at his own request after 11 years as Director General. Johan Färnstrand Johan Färnstrand has during the last couple of years […]
